Amylyx Pharmaceuticals (NASDAQ:AMLX) Given New $8.00 Price Target at Mizuho
Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) had its price objective upped by Mizuho from $7.00 to $8.00 in a research report report published on Wednesday morning,Benzinga reports. Mizuho currently has an outperform rating on the stock. A number of other brokerages also recently issued reports on AMLX. HC Wainwright raised their price target on shares […]
Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) had its price objective upped by Mizuho from $7.00 to $8.00 in a research report report published on Wednesday morning,Benzinga reports. Mizuho currently has an outperform rating on the stock. A number of other brokerages also recently issued reports on AMLX. HC Wainwright raised their price target on shares […]
